The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2011

Filed:

Sep. 19, 2008
Applicants:

Josephus H. M. Lange, Weesp, NL;

Hicham Zilaout, Weesp, NL;

Bernard J. Van Vliet, Weesp, NL;

Inventors:

Josephus H. M. Lange, Weesp, NL;

Hicham Zilaout, Weesp, NL;

Bernard J. Van Vliet, Weesp, NL;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/56 (2006.01); A61K 31/415 (2006.01); C07D 231/06 (2006.01); C07C 233/00 (2006.01); C07C 235/00 (2006.01); C07C 237/00 (2006.01); C07C 239/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention is directed to 5-(hetero)aryl-4,5-dihydro-(1H)-pyrazole (pyrazoline) derivatives as cannabinoid CBreceptor agonists, to pharmaceutical compositions comprising these compounds, to methods for their syntheses, methods for preparing novel intermediates useful for their syntheses, and methods for preparing compositions. The invention also relates to the uses of such compounds and compositions, administered to patients to achieve a therapeutic effect in disorders in which CBreceptors are involved, or that can be treated via manipulation of those receptors. Compounds of the present invention include compounds of formula (I): wherein the substituents have the definitions given in the specification.


Find Patent Forward Citations

Loading…